Published in Ann Surg on February 01, 2009
Extended abdominoperineal excision vs. standard abdominoperineal excision in rectal cancer--a systematic overview. Int J Colorectal Dis (2011) 1.35
Long-term survival and recurrence outcomes following surgery for distal rectal cancer. Ann Surg Oncol (2010) 1.24
Is the 1-cm rule of distal bowel resection margin in rectal cancer based on clinical evidence? A systematic review. Ann Surg Oncol (2011) 1.18
Effectiveness of a transanal tube for the prevention of anastomotic leakage after rectal cancer surgery. World J Surg (2014) 1.04
Intersphincteric resection for very low rectal cancer: a systematic review. Surg Today (2012) 1.04
Laparoscopic intersphincteric resection for low rectal cancer. World J Surg (2011) 1.03
What is the significance of the circumferential margin in locally advanced rectal cancer after neoadjuvant chemoradiotherapy? Ann Surg Oncol (2013) 0.99
Effect of multidisciplinary team treatment on outcomes of patients with gastrointestinal malignancy. World J Gastroenterol (2011) 0.99
Wound dehiscence after abdominoperineal resection for low rectal cancer is associated with decreased survival. Dis Colon Rectum (2014) 0.93
Sphincter-preserving surgery after preoperative radiochemotherapy for T3 low rectal cancers. Oncol Lett (2012) 0.92
Treatment of locally advanced rectal cancer: controversies and questions. World J Gastroenterol (2012) 0.86
Sphincter preservation for distal rectal cancer--a goal worth achieving at all costs? World J Gastroenterol (2011) 0.86
Review of histopathological and molecular prognostic features in colorectal cancer. Cancers (Basel) (2011) 0.85
Current issues in locally advanced colorectal cancer treated by preoperative chemoradiotherapy. World J Gastroenterol (2014) 0.84
Neoadjuvant vs adjuvant pelvic radiotherapy for locally advanced rectal cancer: Which is superior? World J Gastroenterol (2011) 0.83
Completely abdominal intersphincteric resection for lower rectal cancer: feasibility and comparison of robot-assisted and open surgery. Surg Endosc (2014) 0.83
Low-lying rectal cancer with anal canal involvement: abdominoperineal or low anterior resection after neoadjuvant chemoradiotherapy. Gastrointest Cancer Res (2011) 0.82
Abdominoperineal excision following preoperative radiotherapy for rectal cancer: unfavorable prognosis even with negative circumferential resection margin. World J Gastroenterol (2014) 0.81
Racial and ethnic disparities in outcomes with radiation therapy for rectal adenocarcinoma. Int J Colorectal Dis (2011) 0.80
Multidisciplinary treatment of rectal cancer in 2014: where are we going? World J Gastroenterol (2014) 0.80
Surgical issues in locally advanced rectal cancer treated by preoperative chemoradiotherapy. J Korean Surg Soc (2012) 0.78
Proximal and distal rectal cancers differ in curative resectability and local recurrence. World J Gastrointest Surg (2011) 0.78
Analysis of the clinical factors associated with anal function after intersphincteric resection for very low rectal cancer. World J Surg Oncol (2013) 0.78
Risk factors associated with sphincter-preserving resection in patients with low rectal cancer. Int Surg (2014) 0.78
Intersphincteric resection and coloanal anastomosis in treatment of distal rectal cancer. Int J Surg Oncol (2012) 0.76
Preoperative chemoradiotherapy creates an opportunity to perform sphincter preserving resection for low-lying locally advanced rectal cancer based on an oncologic outcome study. Oncotarget (2016) 0.75
Effect of Interval between Neoadjuvant Chemoradiotherapy and Surgery on Oncological Outcome for Rectal Cancer: A Systematic Review and Meta-Analysis. Gastroenterol Res Pract (2016) 0.75
Imaging in rectal cancer with emphasis on local staging with MRI. Indian J Radiol Imaging (2015) 0.75
Superiority of laparoscopic rectal surgery: Towards a new era. World J Gastrointest Surg (2011) 0.75
Surgery: neoadjuvant chemoradiation and sphincter preservation. Nat Rev Gastroenterol Hepatol (2009) 0.75
Low rectal cancer: Sphincter preserving techniques-selection of patients, techniques and outcomes. World J Gastrointest Oncol (2015) 0.75
Is Preoperative Chemoradiotherapy Beneficial for Sphincter Preservation in Low-Lying Rectal Cancer Patients? Medicine (Baltimore) (2016) 0.75
What is the place of intersphincteric resection when operating on low rectal cancer? ISRN Surg (2012) 0.75
Factors Associated With Oncologic Outcomes Following Abdominoperineal or Intersphincteric Resection in Patients Treated With Preoperative Chemoradiotherapy: A Propensity Score Analysis. Medicine (Baltimore) (2015) 0.75
Hospital variation in sphincter preservation for elderly rectal cancer patients. J Surg Res (2014) 0.75
Rectal cancer: a review. Med J Islam Repub Iran (2015) 0.75
Do all locally advanced rectal cancers require radiation? A review of literature in the modern era. J Gastrointest Oncol (2010) 0.75
Matched case-control analysis comparing oncologic outcomes between preoperative and postoperative chemoradiotherapy for rectal cancer. Ann Surg Treat Res (2017) 0.75
Robot-assisted intersphincteric resection facilitates an efficient sphincter-saving in patients with low rectal cancer. Int J Colorectal Dis (2017) 0.75
Cetuximab shows activity in colorectal cancer patients with tumors that do not express the epidermal growth factor receptor by immunohistochemistry. J Clin Oncol (2005) 8.08
Perforation of the gastrointestinal tract secondary to ingestion of foreign bodies. World J Surg (2006) 4.71
Serrated lesions of the colorectum: review and recommendations from an expert panel. Am J Gastroenterol (2012) 4.22
Colorectal cancer surveillance: 2005 update of an American Society of Clinical Oncology practice guideline. J Clin Oncol (2005) 4.10
Adjuvant chemotherapy for stage III colon cancer: implications of race/ethnicity, age, and differentiation. JAMA (2005) 3.46
Relationship of gene expression and chromosomal abnormalities in colorectal cancer. Cancer Res (2006) 3.32
Genomic and biological characterization of exon 4 KRAS mutations in human cancer. Cancer Res (2010) 3.24
Long-term results of RTOG trial 8911 (USA Intergroup 113): a random assignment trial comparison of chemotherapy followed by surgery compared with surgery alone for esophageal cancer. J Clin Oncol (2007) 3.19
Stereotactic radiotherapy for unresectable adenocarcinoma of the pancreas. Cancer (2009) 2.77
Comparative genomic analysis of primary versus metastatic colorectal carcinomas. J Clin Oncol (2012) 2.74
Adequacy of 1-cm distal margin after restorative rectal cancer resection with sharp mesorectal excision and preoperative combined-modality therapy. Ann Surg Oncol (2003) 2.69
Rate of pathologic complete response with increased interval between preoperative combined modality therapy and rectal cancer resection. Dis Colon Rectum (2004) 2.52
Somatic mutations of the Parkinson's disease-associated gene PARK2 in glioblastoma and other human malignancies. Nat Genet (2009) 2.51
Outcome of primary tumor in patients with synchronous stage IV colorectal cancer receiving combination chemotherapy without surgery as initial treatment. J Clin Oncol (2009) 2.50
Follow-up care, surveillance protocol, and secondary prevention measures for survivors of colorectal cancer: American Society of Clinical Oncology clinical practice guideline endorsement. J Clin Oncol (2013) 2.43
American Joint Committee on Cancer staging system does not accurately predict survival in patients receiving multimodality therapy for esophageal adenocarcinoma. J Clin Oncol (2007) 2.41
Predictive factors of malignancy in adults with intussusception. World J Surg (2006) 2.37
Definition and grading of anastomotic leakage following anterior resection of the rectum: a proposal by the International Study Group of Rectal Cancer. Surgery (2009) 2.29
Pathologic classification and clinical behavior of the spectrum of goblet cell carcinoid tumors of the appendix. Am J Surg Pathol (2008) 2.27
Long-term survival following treatment of pseudomyxoma peritonei: an analysis of surgical therapy. Ann Surg (2005) 2.19
The relationship of pathologic tumor regression grade (TRG) and outcomes after preoperative therapy in rectal cancer. Int J Radiat Oncol Biol Phys (2005) 2.18
Elective bowel resection for incurable stage IV colorectal cancer: prognostic variables for asymptomatic patients. J Am Coll Surg (2003) 2.16
Molecular co-expression of the c-Met oncogene and hepatocyte growth factor in primary colon cancer predicts tumor stage and clinical outcome. Cancer Lett (2006) 2.12
Phase II study to assess the efficacy of conventionally fractionated radiotherapy followed by a stereotactic radiosurgery boost in patients with locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys (2005) 2.10
The tyrosine phosphatase PTPRD is a tumor suppressor that is frequently inactivated and mutated in glioblastoma and other human cancers. Proc Natl Acad Sci U S A (2009) 2.09
Phase II randomized trial of two nonoperative regimens of induction chemotherapy followed by chemoradiation in patients with localized carcinoma of the esophagus: RTOG 0113. J Clin Oncol (2008) 2.07
The management of patients with T1 adenocarcinoma of the low rectum: a decision analysis. Dis Colon Rectum (2013) 2.07
Have the changes in treatment of rectal cancer made a significant difference to our patients? Oncology (Williston Park) (2011) 2.06
Whole body 18FDG-PET and the response of esophageal cancer to induction therapy: results of a prospective trial. J Clin Oncol (2003) 2.04
BLM heterozygosity and the risk of colorectal cancer. Science (2002) 2.03
gamma-Secretase inhibitors abrogate oxaliplatin-induced activation of the Notch-1 signaling pathway in colon cancer cells resulting in enhanced chemosensitivity. Cancer Res (2009) 1.98
Counting alleles to predict recurrence of early-stage colorectal cancers. Lancet (2002) 1.96
Operative blood loss independently predicts recurrence and survival after resection of hepatocellular carcinoma. Ann Surg (2009) 1.94
cT3N0 rectal cancer: potential overtreatment with preoperative chemoradiotherapy is warranted. J Clin Oncol (2008) 1.93
Rectus flap reconstruction decreases perineal wound complications after pelvic chemoradiation and surgery: a cohort study. Ann Surg Oncol (2005) 1.92
The role of abdominoperineal resection as surgical therapy for anorectal melanoma. Ann Surg (2006) 1.90
Radiotherapy for liver metastases: a review of evidence. Int J Radiat Oncol Biol Phys (2012) 1.85
Accuracy of endorectal ultrasonography in preoperative staging of rectal tumors. Dis Colon Rectum (2002) 1.83
Gemcitabine chemotherapy and single-fraction stereotactic body radiotherapy for locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys (2008) 1.81
L576P KIT mutation in anal melanomas correlates with KIT protein expression and is sensitive to specific kinase inhibition. Int J Cancer (2007) 1.76
Comparative sequencing analysis reveals high genomic concordance between matched primary and metastatic colorectal cancer lesions. Genome Biol (2014) 1.76
Use of surgery among elderly patients with stage IV colorectal cancer. J Clin Oncol (2004) 1.74
Association of survival and disease progression with chromosomal instability: a genomic exploration of colorectal cancer. Proc Natl Acad Sci U S A (2009) 1.72
c-Met gene amplification is associated with advanced stage colorectal cancer and liver metastases. Cancer Lett (2008) 1.71
Epidermal growth factor receptor expression and gene amplification in colorectal carcinoma: an immunohistochemical and chromogenic in situ hybridization study. Mod Pathol (2005) 1.67
Long-term prognostic significance of extent of rectal cancer response to preoperative radiation and chemotherapy. Ann Surg (2002) 1.66
Assessing the predictive value of clinical complete response to neoadjuvant therapy for rectal cancer: an analysis of 488 patients. J Am Coll Surg (2002) 1.65
Long-term oncologic outcome following preoperative combined modality therapy and total mesorectal excision of locally advanced rectal cancer. Ann Surg (2005) 1.64
Close distal margin and rectal cancer recurrence after sphincter-preserving rectal resection. Dis Colon Rectum (2010) 1.64
Residual mesorectal lymph node involvement following neoadjuvant combined-modality therapy: rationale for radical resection? Ann Surg Oncol (2004) 1.62
Selection of endometrial carcinomas for DNA mismatch repair protein immunohistochemistry using patient age and tumor morphology enhances detection of mismatch repair abnormalities. Am J Surg Pathol (2009) 1.62
Extranodal follicular dendritic cell sarcoma: clinical, pathologic, and histogenetic characteristics of an underrecognized disease entity. Virchows Arch (2006) 1.62
18Fluorodeoxyglucose PET is prognostic of progression-free and overall survival in locally advanced pancreas cancer treated with stereotactic radiotherapy. Int J Radiat Oncol Biol Phys (2010) 1.61
Individualized prediction of colon cancer recurrence using a nomogram. J Clin Oncol (2008) 1.61
Prognostic significance of depth of gross or microscopic perirectal fat invasion in T3 N0 M0 rectal cancers following sharp mesorectal excision and no adjuvant therapy. Int J Colorectal Dis (2003) 1.59
Neoadjuvant chemotherapy without routine use of radiation therapy for patients with locally advanced rectal cancer: a pilot trial. J Clin Oncol (2014) 1.59
Nonoperative management of rectal cancer with complete clinical response after neoadjuvant therapy. Ann Surg (2012) 1.58
Patterns of morphologic alteration in residual rectal carcinoma following preoperative chemoradiation and their association with long-term outcome. Am J Surg Pathol (2004) 1.58
Single-fraction stereotactic body radiation therapy and sequential gemcitabine for the treatment of locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys (2011) 1.57
Comparison of adjuvant systemic chemotherapy with or without hepatic arterial infusional chemotherapy after hepatic resection for metastatic colorectal cancer. Ann Surg (2011) 1.57
Anastomotic leak is not associated with oncologic outcome in patients undergoing low anterior resection for rectal cancer. Ann Surg (2012) 1.57
Effects of obesity in rectal cancer surgery. J Am Coll Surg (2010) 1.56